| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |